CytRx Co. Reaches New 12-Month High at $7.30 (CYTR)
Shares of CytRx (NASDAQ:CYTR) hit a new 52-week high during trading on Thursday, Stock Ratings Network reports. The stock traded as high as $7.30 and last traded at $7.14, with a volume of 7,817,665 shares trading hands. The stock had previously closed at $6.27.
A number of analysts have recently weighed in on CYTR shares. Analysts at Thomson Reuters/Verus downgraded shares of CytRx from a “hold” rating to a “sell” rating in a research note to investors on Tuesday, December 24th. Separately, analysts at Aegis raised their price target on shares of CytRx from $7.00 to $8.00 in a research note to investors on Thursday, December 12th. They now have a “buy” rating on the stock. Finally, analysts at Aegis reiterated a “buy” rating on shares of CytRx in a research note to investors on Monday, November 25th. One analyst has rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company’s stock. CytRx presently has an average rating of “Hold” and an average target price of $5.95.
CytRx has a one year low of $1.83 and a one year high of $6.79. The stock’s 50-day moving average is $3.48 and its 200-day moving average is $2.69. The company’s market cap is $300.5 million.
CytRx (NASDAQ:CYTR) last issued its quarterly earnings data on Tuesday, October 29th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.11. During the same quarter in the previous year, the company posted $0.07 earnings per share. On average, analysts predict that CytRx will post $-0.73 earnings per share for the current fiscal year.
CytRx Corporation as (NASDAQ:CYTR) is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, specializing in oncology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.